Principal Financial Group Inc. lowered its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 2.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,606,511 shares of the company's stock after selling 46,254 shares during the quarter. Principal Financial Group Inc. owned about 1.19% of AdaptHealth worth $17,415,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the stock. Reinhart Partners LLC. boosted its position in AdaptHealth by 15.5% during the first quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company's stock worth $78,441,000 after purchasing an additional 969,408 shares during the period. Segall Bryant & Hamill LLC boosted its position in AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock worth $45,734,000 after purchasing an additional 1,102,173 shares during the period. Dimensional Fund Advisors LP boosted its position in AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock worth $32,174,000 after purchasing an additional 505,180 shares during the period. Geode Capital Management LLC boosted its position in AdaptHealth by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock worth $23,499,000 after purchasing an additional 16,596 shares during the period. Finally, Kennedy Capital Management LLC boosted its position in AdaptHealth by 6.0% during the fourth quarter. Kennedy Capital Management LLC now owns 1,767,310 shares of the company's stock worth $16,825,000 after purchasing an additional 99,326 shares during the period. Institutional investors own 82.67% of the company's stock.
AdaptHealth Stock Performance
Shares of AHCO stock traded down $0.23 during trading hours on Friday, reaching $9.22. 848,930 shares of the company's stock were exchanged, compared to its average volume of 1,332,750. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The stock has a market capitalization of $1.24 billion, a P/E ratio of 16.18, a P/E/G ratio of 1.07 and a beta of 1.63. The business has a fifty day moving average price of $8.93 and a 200-day moving average price of $9.41. The company has a quick ratio of 1.07, a current ratio of 1.29 and a debt-to-equity ratio of 1.25.
Analyst Upgrades and Downgrades
AHCO has been the subject of a number of recent analyst reports. Truist Financial decreased their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Royal Bank Of Canada cut their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and an average target price of $13.40.
Get Our Latest Analysis on AHCO
AdaptHealth Company Profile
(
Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Read More

Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.